$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024022314 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$30.64M	$35.44M
YoY Change	35.29%	59.6%
Cost Of Revenue	$22.93M	$22.45M
YoY Change	51.47%	60.81%
Gross Profit	$7.710M	$12.99M
YoY Change	2.68%	57.55%
Gross Profit Margin	25.16%	36.66%
Selling, General & Admin	$1.700M	$4.231M
YoY Change	-35.01%	62.28%
% of Gross Profit	22.04%	32.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$3.121M	$6.045M
YoY Change	-37.34%	142.53%
Operating Profit	$4.589M	$6.948M
YoY Change	81.48%	20.75%
Interest Expense	-$10.27K	$4.630K
YoY Change	-4990.48%	-109.42%
% of Operating Profit	-0.22%	0.07%
Other Income/Expense, Net
YoY Change
Pretax Income	$4.597M	$6.991M
YoY Change	78.58%	21.45%
Income Tax	-$1.030K	$10.89K
% Of Pretax Income	-0.02%	0.16%
Net Earnings	$4.598M	$6.980M
YoY Change	78.63%	21.04%
Net Earnings / Revenue	15.01%	19.69%
Basic Earnings Per Share	$0.07	$0.11
Diluted Earnings Per Share	$0.07	$0.11
COMMON SHARES
Basic Shares Outstanding	52.26M shares	52.25M shares
Diluted Shares Outstanding	52.27M shares	52.25M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.14M	$64.57M
YoY Change	-33.87%	-34.49%
Cash & Equivalents	$65.14M	$64.57M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$106.3M	$90.36M
YoY Change	1.82%	-13.95%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.457M	$72.18K
YoY Change	14.39%	-96.29%
Total Long-Term Assets	$1.191B	$1.288B
YoY Change	16.55%	26.08%
TOTAL ASSETS
Total Short-Term Assets	$106.3M	$90.36M
Total Long-Term Assets	$1.191B	$1.288B
Total Assets	$1.297B	$1.378B
YoY Change	15.18%	22.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.365M	$3.851M
YoY Change	32.36%	53.72%
Deferred Revenue
YoY Change
Short-Term Debt	$995.9M	$1.076B
YoY Change	19.91%	29.64%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.007B	$1.087B
YoY Change	20.01%	29.69%
LONG-TERM LIABILITIES
Long-Term Debt	$47.34M	$47.28M
YoY Change	0.53%	0.53%
Other Long-Term Liabilities	$700.4K	$501.7K
YoY Change	-24.99%	37.1%
Total Long-Term Liabilities	$48.04M	$47.78M
YoY Change	0.03%	1.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.007B	$1.087B
Total Long-Term Liabilities	$48.04M	$47.78M
Total Liabilities	$1.055B	$1.135B
YoY Change	18.92%	28.19%
SHAREHOLDERS EQUITY
Retained Earnings	$58.95M	$54.35M
YoY Change	63.76%	62.61%
Common Stock	$522.8K	$522.6K
YoY Change	0.08%	0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$242.1M	$242.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.297B	$1.378B
YoY Change	15.18%	22.35%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$4.598M	$6.980M
YoY Change	78.63%	21.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$5.514M	$9.058M
YoY Change	29.86%	55.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$82.18M	$80.09M
YoY Change	-12323.16%	55.14%
Cash From Investing Activities	$82.18M	$80.09M
YoY Change	-12323.16%	55.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-85.75M	-$76.02M
YoY Change	1883.65%	1661.78%
NET CHANGE
Cash From Operating Activities	5.514M	$9.058M
Cash From Investing Activities	82.18M	$80.09M
Cash From Financing Activities	-85.75M	-$76.02M
Net Change In Cash	1.947M	$13.13M
YoY Change	-359.86%	-75.3%
FREE CASH FLOW
Cash From Operating Activities	$5.514M	$9.058M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-49129	usd
CY2024Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	38503	usd
CY2023Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	51528	usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2024Q1	oaks	Interest Expense Collateralized Loan Obligations And Secured Financings InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings	21511754	usd
CY2023Q1	oaks	Interest Expense Collateralized Loan Obligations And Secured Financings InterestExpenseCollateralizedLoanObligationsAndSecuredFinancings	13033046	usd
CY2024Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	937210	usd
CY2023Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	926912	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12992557	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8246368	usd
CY2024Q1	oaks	Management And Incentive Fees ManagementAndIncentiveFees	2568207	usd
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	4267740	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	2672006	usd
CY2024Q1	oaks	Financing Receivable Excluding Accrued Interest Including Loss On Unfunded Loan Commitments Expense Reversal FinancingReceivableExcludingAccruedInterestIncludingLossOnUnfundedLoanCommitmentsExpenseReversal	1776873	usd
CY2023Q1	oaks	Management And Incentive Fees ManagementAndIncentiveFees	1087262	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1134136	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	948066	usd
CY2024Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	470167	usd
CY2023Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	509986	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-36480	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-64584	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	58750	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	62108	usd
CY2023Q1	oaks	Financing Receivable Excluding Accrued Interest Including Loss On Unfunded Loan Commitments Expense Reversal FinancingReceivableExcludingAccruedInterestIncludingLossOnUnfundedLoanCommitmentsExpenseReversal	-179684	usd
CY2024Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	4627	usd
CY2024Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-1733743	usd
CY2023Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	182083	usd
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	6991074	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	5756445	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10892	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10246	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6980182	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5766691	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1184999	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1184958	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5795183	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4581733	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5795183	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5795183	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4581733	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4581733	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52249299	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231152	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240792380	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19947	usd
CY2024Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14196	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6980182	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3658012	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184999	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	242935302	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	243001497	usd
CY2023Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14040	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3358	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5766691	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184958	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240847239	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6980182	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5766691	usd
CY2024Q1	oaks	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	711236	usd
CY2023Q1	oaks	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	0	usd
CY2024Q1	oaks	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	0	usd
CY2023Q1	oaks	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	5287	usd
CY2024Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	57323	usd
CY2023Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	64293	usd
CY2024Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-14196	usd
CY2023Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-14040	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	945782	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	684771	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1757456	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	-179684	usd
CY2024Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	4627	usd
CY2023Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-49129	usd
CY2024Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	usd
CY2023Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	3358	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-125527	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	141184	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-665703	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	150577	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-242085	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	144100	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1484625	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-2333	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1871916	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-259282	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9057892	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5841943	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	0	usd
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	80093383	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	51625741	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	80093383	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	51625741	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19947	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	71204206	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3657404	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3133869	usd
CY2024Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1181250	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1181250	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76022913	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4315119	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13128362	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	53152565	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51517192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64645554	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100518930	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	21745268	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	13131087	usd
CY2024Q1	oaks	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4659261	usd
CY2023Q1	oaks	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4318827	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amount and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the financial statements and the reported amounts of certain revenues and expenses during the reported period. It is likely that changes in these estimates (e.g. valuation changes due to supply and demand, credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company's estimates are inherently subjective in nature and actual results could differ from its estimates and the differences may be material.</span></div>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64573372	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51247063	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64645554	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51517192	usd
CY2024Q1	oaks	Number Of Commercial Real Estate Loans Included In Loan Performance Analytical Model NumberOfCommercialRealEstateLoansIncludedInLoanPerformanceAnalyticalModel	125000	loan
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1076148186	usd
CY2022Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	4258668	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1071889518	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	583989	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31250852	usd
CY2024Q1	oaks	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52257315	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52257315	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	7816462	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2024Q1	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0532
CY2023Q4	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2024Q1	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0040
CY2023Q4	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0038
CY2024Q1	oaks	Weighted Average Floating Rate WeightedAverageFloatingRate	1.000
CY2024Q1	oaks	Average Risk Rate AverageRiskRate	3.5
CY2023Q4	oaks	Average Risk Rate AverageRiskRate	3.5
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	7816462	usd
CY2024Q1	oaks	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	63064	usd
CY2024Q1	oaks	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments	7879526	usd
CY2024Q1	oaks	Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss	1299971777	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6059006	usd
CY2023Q4	oaks	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	43647	usd
CY2023Q4	oaks	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Including Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestIncludingUnfundedLoanCommitments	6102653	usd
CY2023Q4	oaks	Financing Receivable Excluding Accrued Interest Net Of Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestNetOfAllowanceForCreditLoss	1397385160	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	1800000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	7800000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	6000000	usd
CY2022	oaks	Reserve For Impaired Loan ReserveForImpairedLoan	4300000	usd
CY2023Q1	oaks	Reserve For Impaired Loan ReserveForImpairedLoan	4300000	usd
CY2021Q2	oaks	Number Of Newly Formed Subsidiaries NumberOfNewlyFormedSubsidiaries	2	subsidiary
CY2021Q2	oaks	Variable Interest Entity Qualitative And Quantitative Information Equity Interest VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest	96250000	usd
CY2021Q2	oaks	Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations	330300000	usd
CY2021Q2	oaks	Period To Acquire Additional Loan Obligations From Closing Date PeriodToAcquireAdditionalLoanObligationsFromClosingDate	P180D
CY2021Q2	oaks	Collateralized Loan Obligation Leverage Ratio CollateralizedLoanObligationLeverageRatio	0.83
CY2024Q1	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0532
CY2023Q4	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2024Q1	oaks	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0040
CY2023Q4	oaks	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0038
CY2024Q1	oaks	Financing Receivable Sofr Spread Rate FinancingReceivableSOFRSpreadRate	0.0360
CY2023Q4	oaks	Financing Receivable Sofr Spread Rate FinancingReceivableSOFRSpreadRate	0.0354
CY2024Q1	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0203
CY2023	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0199
CY2019Q1	oaks	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	usd
CY2024Q1	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	467648	usd
CY2023Q4	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	529774	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2024Q1	oaks	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	696600	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	691973	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1383881197	usd
CY2024Q1	oaks	Annual Management Fee Percentage AnnualManagementFeePercentage	0.015
CY2024Q1	oaks	Quarterly Management Fee Percentage QuarterlyManagementFeePercentage	0.00375
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52257315	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52257315	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52248631	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52248631	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2023Q2	oaks	Fair Market Value Average Closing Prices Share Of Common Stock Reported Nyse Period FairMarketValueAverageClosingPricesShareOfCommonStockReportedNYSEPeriod	10	tradingday
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6980182	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5766691	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3658012	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184999	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184958	usd
CY2024Q1	us-gaap	Dividends Dividends	4843011	usd
CY2023Q1	us-gaap	Dividends Dividends	4318827	usd
CY2024Q1	us-gaap	Undistributed Earnings UndistributedEarnings	2137171	usd
CY2023Q1	us-gaap	Undistributed Earnings UndistributedEarnings	1447864	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52249299	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52225152	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52249299	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231152	shares

Files In Submission

Name	View Source	Status
0001628280-24-022314-index-headers.html	Edgar Link	pending
0001628280-24-022314-index.html	Edgar Link	pending
0001628280-24-022314.txt	Edgar Link	pending
0001628280-24-022314-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lft10-q20240331_ex31x1.htm	Edgar Link	pending
lft10-q20240331_ex31x2.htm	Edgar Link	pending
lft10-q20240331_ex32x1.htm	Edgar Link	pending
lft10-q20240331_ex32x2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oaks-20240331.htm	Edgar Link	pending
oaks-20240331.xsd	Edgar Link	pending
oaks-20240331_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
oaks-20240331_cal.xml	Edgar Link	unprocessable
oaks-20240331_def.xml	Edgar Link	unprocessable
oaks-20240331_lab.xml	Edgar Link	unprocessable
oaks-20240331_pre.xml	Edgar Link	unprocessable
oaks-20240331_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2024 Q2 Form 10-Q Financial Statement

#000162828024022314 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2024 Q2 Form 10-Q Financial Statement

#000162828024022314 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft